[Federal Register Volume 69, Number 20 (Friday, January 30, 2004)]
[Notices]
[Pages 4524-4525]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-1996]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Centers Review Committee.
    Date: February 23-24, 2004.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 
20892-8401, (301) 435-1388.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Medication Development Research Subcommittee.
    Date: March 1, 2004.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin Grand, 2350 M Street, NW., Washington, DC 20037.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Development Conflicts.
    Date: March 1, 2004.
    Time: 4 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 4525]]

    Place: Westin Grand, 2350 M Street, NW., Washington, DC 20037.
    Contact Person: Eliane Lazar-Wesley, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401, 301-451-4530.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Health Services Research Subcommittee.
    Date: March 2-3, 2004.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Mark R. Green, PhD, Chief, CEASRB, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1431.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Treatment Research Subcommittee.
    Date: March 2-3, 2004.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Kesinee Nimit, MD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401, (301) 435-1432.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Member Conflict.
    Date: March 3, 2004.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Teresa Levitin, PhD, Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Training and Career Development Subcommittee.
    Date: March 9-11, 2004.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Mark Swieter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6101 Executive 
Boulevard, Suite 234, Bethesda, MD 20892-8401, (301) 435-1389.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, RFA DA04-004, NIDA Neuroproteomics Research Centers 
(NIDA NPRCs).
    Date: March 14-16, 2004.
    Time: 7 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 
20892-8401, (301) 435-1388.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Centers.
    Date: March 22, 2004.
    Time: 8 a.m. to 7:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 200, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401, (301) 443-2755.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: January 23, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-1996 Filed 1-29-04; 8:45 am]
BILLING CODE 4140-01-M